Trials / Active Not Recruiting
Active Not RecruitingNCT06230757
Psilocybin for Treatment-Resistant Depression
Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of psilocybin on the symptom of anhedonia in individuals with treatment-resistant major depressive disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Psilocybin 25mg | 25mg psilocybin capsule |
| DRUG | Placebo (active placebo) | 1mg psilocybin capsule |
Timeline
- Start date
- 2024-07-08
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2024-01-30
- Last updated
- 2026-01-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06230757. Inclusion in this directory is not an endorsement.